HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SCH 221153

structure in first source

Also Known As:

SCH221153

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - SCH 221153: 1

Experts

1.	Armstrong, L: 1 article (03/2001)
2.	Kumar, C C: 1 article (03/2001)
3.	Liu, M: 1 article (03/2001)
4.	Malkowski, M: 1 article (03/2001)
5.	Nechuta, T: 1 article (03/2001)
6.	Neustadt, B: 1 article (03/2001)
7.	Presta, M: 1 article (03/2001)
8.	Smith, E M: 1 article (03/2001)
9.	Tanghetti, E: 1 article (03/2001)
10.	Varner, J: 1 article (03/2001)

Related Diseases

1.	Neoplasms (Cancer) 03/01/2001 - "Finally, SCH 221153 exerted a significant inhibition on tumor growth induced by intradermal or s.c. " 03/01/2001 - "Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist."

Related Drugs and Biologics

1.	integrin beta5